Merck news
Latest News From Merck Pharmaceutical Company
Merck Asks US To Reconsider Singulair Patent Rejection
Merck Asks US To Reconsider Singulair Patent Rejection
CNNMoney.com - 13 minutes ago
Merck & Co. (MRK) has asked the US Patent and Trademark Office to reconsider its tentative rejection of Merck's patent for the blockbuster asthma drug Singulair. In early September, after re ...
Upgrades: ANF, ADBE, MRK
Upgrades: ANF, ADBE, MRK
MarketNewsVideo.com - 18 minutes ago
This morning, Goldman Sachs upgraded shares of Abercrombie & Fitch (NYSE:ANF) from Neutral to Buy as sales trends improve. The company is set to open more stores, increasing the pace of new stores ...
Cardiome gets boost from Merck
Cardiome gets boost from Merck
Globe and Mail - 29 minutes ago
Vancouver — The Canadian Press Published on Monday, Nov. 09, 2009 10:35AM EST Last updated on Monday, Nov. 09, 2009 10:37AM EST Cardiome Pharma Corp. COM-T reported Monday a third-quarter net loss ...
Insmed Inc. Reports Operating Results (10-Q)
Insmed Inc. Reports Operating Results (10-Q)
GuruFocus.com - 51 minutes ago
Insmed Pharmaceuticals is a development stage pharmaceutical company that is developing drugs to treat metabolic and endocrine diseases associated with insulin resistance. The company's first drug ...
New Merck Begins Operations
New Merck Begins Operations
PR-CANADA.net - 2 minutes ago
WHITEHOUSE STATION, NJ– Merck & Co., Inc. (NYSE: MRK) today outlined its global plans following the completion of Merck's merger with Schering-Plough Corporation announced yesterday. The new Merck ...
Merck poised for more growth
Merck poised for more growth
Fort Wayne Journal Gazette - 10 minutes ago
AP TRENTON, NJ – The new Merck & Co. has become the world's second-biggest drugmaker overnight with a huge acquisition, but it still has a fat wallet and plans more wheeling and dealing. A day ...
Drug firm Merck & Co today said it has formed a joint venture with
Drug firm Merck & Co today said it has formed a joint venture with
mydigitalfc.com - 17 minutes ago
"We along with charitable organisation Welcome Trust have formed a 50:50 joint venture, which would be based in India and would conduct research and development activities in the field of vaccines ...
